Efficacy of brimonidine as replacement therapy in patients with open-angle glaucoma or ocular hypertension
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (1) , 53-65
- https://doi.org/10.1016/s0149-2918(00)87977-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Effectiveness and Safety of Brimonidine as Mono-, Combination, or Replacement Therapy for Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Post Hoc Analysis of an Open-Label Community TrialJournal of Ocular Pharmacology and Therapeutics, 2000
- Intraocular Pressure-Lowering Effects of Latanoprost Monotherapy versus Latanoprost or Pilocarpine in Combination with TimololJournal of Glaucoma, 1999
- Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patientsAmerican Journal of Ophthalmology, 1999
- Latanoprost treatment for glaucoma: effects of treating for 1 year and of switching from timololAmerican Journal of Ophthalmology, 1998
- Changing therapeutic paradigms in glaucoma managementExpert Opinion on Investigational Drugs, 1998
- BrimonidineExpert Opinion on Investigational Drugs, 1997
- A 1-Year Study of Brimonidine Twice Daily in Glaucoma and Ocular HypertensionArchives of Ophthalmology (1950), 1997
- A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressureSurvey of Ophthalmology, 1996
- Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: A review of safety, efficacy, dose response, and dosing studiesSurvey of Ophthalmology, 1996
- Effects of Brimonidine on Aqueous Humor Dynamics in Human EyesArchives of Ophthalmology (1950), 1995